Table 1. Clinical characteristics and plasma legumain levels.
CAD (−) | P value | CAD | Complex lesion (−) | Complex lesion | Complex lesion (+) | |
---|---|---|---|---|---|---|
(n = 147) | CAD (−) vs. CAD | (n = 225) | (n = 185) | (+) vs. (−) | (n = 40) | |
Age (years) | 66 ± 10 | < 0.001 | 69 ± 10 | 69 ± 10 | 0.49 | 68 ± 10 |
Gender (male) | 88 (60%) | < 0.001 | 174 (77%) | 142 (77%) | 0.90 | 32 (80%) |
Hypertension | 89 (61%) | < 0.001 | 176 (78%) | 148 (80%) | 0.30 | 28 (70%) |
SBP (mmHg) | 130 ± 21 | 0.20 | 133 ± 20 | 133 ± 21 | 0.76 | 132 ± 19 |
Diabetes mellitus | 22 (15%) | < 0.001 | 83 (37%) | 70 (38%) | 0.80 | 13 (33%) |
Smoking | 46 (31%) | 0.10 | 92 (41%) | 78 (42%) | 0.80 | 14 (35%) |
Hyperlipidemia | 67 (46%) | < 0.025 | 132 (59%) | 109 (59%) | 0.98 | 23 (58%) |
Statin | 45 (31%) | < 0.01 | 101 (45%) | 88 (48%) | 0.20 | 13 (33%) |
LDL-C (mg/dL) | 113 ± 28 | 0.72 | 114 ± 32 | 111 ± 32 | < 0.005 | 127 ± 28 |
HDL-C (mg/dL) | 60 ± 14 | < 0.001 | 51 ± 13 | 51 ± 14 | 0.99 | 51 ± 13 |
hsCRP levels | 0.46 | < 0.001 | 0.60 | 0.60 | 0.93 | 0.60 |
(mg/L) | [0.22, 0.89] | [0.32, 1.53] | [0.32, 1.51] | [0.34, 1.53] | ||
> 1.0mg/L | 33 (22%) | < 0.025 | 78 (35%) | 65 (35%) | 0.90 | 13 (33%) |
Legumain levels | 4.99 | 0.81 | 5.08 | 4.93 | < 0.01 | 6.05 |
(ng/mL) | [3.84, 6.88] | [3.87, 6.82] | [3.76, 6.52] | [4.64, 8.64] | ||
> 5.5 ng/mL | 58 (39%) | 0.90 | 92 (41%) | 68 (37%) | < 0.025 | 24 (60%) |
Data are presented as the mean ± SD or the number (%) of patients, except for hsCRP and legumain levels, which are presented as the median value and interquartile range.
SBP indicates systolic blood pressure; LDL-C, LDL-cholesterol; and HDL-C, HDL-cholesterol.